This site is intended for healthcare professionals
  • Home
  • /
  • News & Insights
  • /
  • News trends
  • /
  • Transplant organ rejection
  • /
  • Challenges in transplant organ rejection

Challenges in transplant organ rejection

Read time: 5 mins
Last updated:13th Oct 2021
Published:10th Aug 2020
Since the first successful organ transplant procedures in the 1950s, immunosuppressive agents have played a key role by reducing grafted organ rejection and improving patient survival. In this series of articles, we’ll give updates on the various existing treatments as well as on the horizon for transplant organ rejection.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest


  1. Claeys E, Vermeire K, Leuven KU. Immunosuppressive drugs in organ transplantation to prevent allograft rejection: Mode of action and side effects. J Immunol Sci. 2019;3(4):14–21.
  2. Daniel Abramowicz, Oberbauer R, Heemann U, Viklicky O, Peruzzi L, Mariat C, et al. Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board. Nephrol Dial Transpl. 2018;33(10):1699–1707.
  3. Saldanha IJ, Akinyede O, Robinson KA. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis. Cochrane Database Syst Rev. 2018;6(6). doi:10.1002/14651858.CD009421.pub4.
  4. Benvenuto LJ, Anderson MR, Arcasoy SM. New frontiers in immunosuppression. J Thorac Dis. 2018;10(5):3141–3155.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.